Immune Checkpoint Therapy Combinations in Adult Advanced MiT Family Translocation Renal Cell Carcinomas

BACKGROUND: There remains a paucity of data regarding the efficacy of immune checkpoint therapy (ICT) combinations ± vascular endothelial growth factor (VEGF) targeted therapy (TT) in translocation renal cell carcinoma (tRCC). METHODS: This is a retrospective study of patients with advanced tRCC tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Alhalabi, Omar, Thouvenin, Jonathan, Négrier, Sylvie, Vano, Yann-Alexandre, Campedel, Luca, Hasanov, Elshad, Bakouny, Ziad, Hahn, Andrew W, Bilen, Mehmet Asim, Msaouel, Pavlos, Choueiri, Toni K, Viswanathan, Srinivas R, Sircar, Kanishka, Albiges, Laurence, Malouf, Gabriel G, Tannir, Nizar M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Genitourinary Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166175/
https://www.ncbi.nlm.nih.gov/pubmed/36640141
http://dx.doi.org/10.1093/oncolo/oyac262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10166175/
https://www.ncbi.nlm.nih.gov/pubmed/36640141
http://dx.doi.org/10.1093/oncolo/oyac262

Ejemplares similares